Medical equipment manufacturer Mindray Medical International has signed a definitive agreement to acquire a controlling stake of Wuhan Dragonbio Surgical Implant for $35.5 million.
Wuhan Dragonbio provides medical orthopedic products in the Chinese market for trauma, spine, joint, and other surgical procedures, Mindray said. The company had total revenues of approximately $7.7 million in 2011.
Mindray anticipates the transaction will be completed next month.
